Alain Rouillard

Title: The Innovative Contributions of Alain Rouillard

Introduction

Alain Rouillard is a notable inventor based in Québec, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of gastrointestinal disorders. His work focuses on developing innovative compounds that address various gastrointestinal issues.

Latest Patents

Alain Rouillard holds a patent for "Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders." This invention provides conformationally-defined macrocyclic compounds that bind to and/or are functional modulators of the motilin receptor. These compounds are designed to be therapeutics for a range of disease indications, particularly for disorders characterized by hypermotilinemia and gastrointestinal hypermotility. The patent outlines the utility of these compounds in treating conditions such as diarrhea, irritable bowel syndrome, and inflammatory bowel diseases, among others.

Career Highlights

Rouillard is currently associated with Ocera Therapeutics, Inc., where he continues to advance his research and development efforts. His work has the potential to significantly improve the quality of life for patients suffering from gastrointestinal disorders.

Collaborations

Alain Rouillard has collaborated with notable colleagues, including Eric Marsault and Graeme Lovat Fraser. These partnerships have contributed to the advancement of his research and the development of innovative therapeutic solutions.

Conclusion

Alain Rouillard's contributions to the field of pharmaceuticals, particularly through his patent on macrocyclic antagonists, highlight his commitment to addressing critical health issues. His work exemplifies the importance of innovation in developing effective treatments for gastrointestinal disorders.